ALDH9A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.862600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.683600E-01
Normal-vs-Stage2
6.835200E-01
Normal-vs-Stage3
2.865600E-01
Normal-vs-Stage4
8.075400E-01
Stage1-vs-Stage2
4.030300E-02
Stage1-vs-Stage3
7.171800E-02
Stage1-vs-Stage4
5.453800E-01
Stage2-vs-Stage3
3.264600E-01
Stage2-vs-Stage4
4.033200E-01
Stage3-vs-Stage4
1.307420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.438200E-01
Normal-vs-AfricanAmerican
5.095400E-01
Normal-vs-Asian
7.480200E-01
Caucasian-vs-AfricanAmerican
6.516100E-02
Caucasian-vs-Asian
9.674000E-01
AfricanAmerican-vs-Asian
1.637160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.471600E-01
Normal-vs-Female
9.405000E-01
Male-vs-Female
1.949400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.734400E-01
Normal-vs-Age(41-60Yrs)
9.557800E-01
Normal-vs-Age(61-80Yrs)
7.343200E-01
Normal-vs-Age(81-100Yrs)
7.269800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.516400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.976400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.246400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.935600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.200400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.477000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.181400E-01
Normal-vs-Daily Drinker
2.484200E-01
Normal-vs-Weekly Drinker
3.991400E-01
Normal-vs-Occasional Drinker
8.136600E-01
Normal-vs-Social Drinker
9.065000E-01
Non Drinker-vs-Daily Drinker
2.181600E-01
Non Drinker-vs-Weekly Drinker
7.352400E-01
Non Drinker-vs-Occasional Drinker
1.561430E-01
Non Drinker-vs-Social Drinker
3.686600E-01
Daily Drinker-vs-Weekly Drinker
4.548400E-01
Daily Drinker-vs-Occasional Drinker
3.749900E-02
Daily Drinker-vs-Social Drinker
7.966100E-02
Weekly Drinker-vs-Occasional Drinker
1.160790E-01
Weekly Drinker-vs-Social Drinker
2.996200E-01
Occasional Drinker-vs-Social Drinker
5.234800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.324640E-01
Normal-vs-Grade 2
6.692000E-02
Normal-vs-Grade 3
1.279150E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.964600E-01
Grade 1-vs-Grade 3
1.255420E-01
Grade 1-vs-Grade 4
1.324640E-01
Grade 2-vs-Grade 3
1.524000E-01
Grade 2-vs-Grade 4
6.692000E-02
Grade 3-vs-Grade 4
1.279150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.171800E-01
Normal-vs-NonDiabetic
7.220400E-01
Diabetic-vs-NonDiabetic
1.222230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.747000E-01
Normal-vs-NoPancreatitis
6.720000E-01
Pancreatitis-vs-NoPancreatitis
6.180600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.351800E-01
Normal-vs-N1
6.375800E-01
N0-vs-N1
1.219230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.061200E-01
Normal-vs-TP53-NonMutant
7.868400E-01
TP53-Mutant-vs-TP53-NonMutant
1.202300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
